Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences…
Bavarian Nordic Announces First Half 2025 Results
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced…
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from…
Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results
NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings…
UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025
Reports AUM of INR 12,081 Cr, up 31% (YoY); Total Income of…
Nexteer Reports Strong First-Half 2025 Results
Driven by Growth with China OEMs, Technology Leadership & Strategic Expansion …
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
August 13, 2025 11:45 ET | Source: Milestone Scientific, Inc. ROSELAND, N.J.,…
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results
Posts Positive Organic Growth and Adjusted EBITDA1 of 23.5% of Revenue CINCINNATI,…
Anteris Announces Results for the Second Quarter of 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies…
